`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`BIOCON BIOLOGICS INC.,
`Petitioner
`
`v.
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner
`
`
`Inter Partes Review No.: IPR2024-00201
`
`
`U.S. Patent No. 10,888,601 B2
`Filed: April 29, 2019
`Issued: January 12, 2021
`Inventor: George D. Yancopoulos
`
`Title: USE OF A VEGF ANTAGONIST TO TREAT
`ANGIOGENIC EYE DISORDERS
`
`
`PETITIONER’S MOTION TO SEAL
`
`37 C.F.R. §§ 42.14 & 42.54
`
`
`
`
`Pursuant to 37 C.F.R. §§ 42.14 & 42.54, Petitioner Biocon Biologics Inc.
`
`(“Petitioner”) moves to seal Exhibit 1062, filed herewith. Exhibit 1062 is an excerpt
`
`of the Pretrial Memorandum submitted in the district court litigation captioned
`
`Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., No. 22-cv-61
`
`(N.D.W. Va. May 26, 2023), which was designated as CONFIDENTIAL and filed
`
`under seal by Patent Owner in that matter. This exhibit was filed concurrently with
`
`Petitioner’s Petition in Inter Partes Review No. IPR2024-00201.
`
`The Board may seal documents for good cause. See 37 C.F.R. § 42.54(a);
`
`Garmin v. Cuozzo, IPR2012-00001, Paper 36, 8-9 (2013). “The rules aim to strike
`
`a balance between the public’s interest in maintaining a complete and
`
`understandable file history and the parties’ interest in protecting truly sensitive
`
`information.” Office Patent Trial Practice Guide, 77 Fed. Reg. 48756, 48760
`
`(2012). The public’s interest in having access to confidential business information
`
`that is only indirectly related to patentability is “minimal.” Garmin v. Cuozzo,
`
`IPR2012-00001, Paper 36, 8-9 (2013) (granting a motion to seal an agreement
`
`relating to the “commercializ[ation]” of the patent-at-issue).
`
`The information that Petitioner seeks to seal has been designated as
`
`CONFIDENTIAL by Patent Owner in the district court litigation pending between
`
`Petitioner and Patent Owner in the Northern District of West Virginia, Civil Action
`
`No. 22-cv-00061-TSK-JPM. Therefore, out of respect for Patent Owner’s
`
`1
`
`
`
`designation of the document as confidential, Petitioner seeks to maintain the same
`
`under seal in the pending inter partes review proceeding. It is Petitioner’s
`
`understanding good cause exists to seal portions of Exhibit 1062 as submitted.
`
`Thus, out of respect for Patent Owner’s confidential designation of Exhibit
`
`1062 in the district court litigation, Petitioner respectfully requests that the Board
`
`grant its motion to seal Exhibit 1062 filed concurrently herewith.
`
`
`
`
`
`2
`
`
`
`Dated: November 20, 2023
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`
`/Paul J. Molino/
`Paul J. Molino
`Registration No. 45,350
`6 West Hubbard Street
`Chicago, IL 60654
`Telephone:
`(312) 222-6300
`Facsimile:
`(312) 843-6260
`paul@rmmslegal.com
`
`
`Counsel for Petitioner
`
`
`
`
`
`
`
`3
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a true and correct copy of the foregoing
`
`PETITIONER’S MOTION TO SEAL WAS served on November 20, 2023, via
`
`FedEx Priority Overnight on the Patent Owner at the correspondence address of
`
`record for U.S. Patent No. 10,888,601 B2 as evidenced in Patent Center:
`
`A&P - Regeneron (Prosecution)
`601 Massachusetts Ave., NW
`Washington, DC 20001-3743
`
`/Paul J. Molino/
`Paul J. Molino (Reg. No. 45,350)
`
`
`
`
`
`
`
`
`
`
`